Healthcare provider profile · identity verified

Lawrence Mark Fleishman, MD

Internal Medicine · CHARLOTTE, NC · NPI 1467471292

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	532	164
Atorvastatin Calcium	Atorvastatin Calcium	392	130
Levothyroxine Sodium	Levothyroxine Sodium	285	78
Omeprazole	Omeprazole	256	78
Pravastatin Sodium	Pravastatin Sodium	242	63
Gabapentin	Gabapentin	207	57
Spironolactone	Spironolactone	207	57
Losartan Potassium	Losartan Potassium	189	65
Metformin Hcl	Metformin Hcl	188	52
Metoprolol Succinate	Metoprolol Succinate	173	46
Simvastatin	Simvastatin	164	46
Rosuvastatin Calcium	Rosuvastatin Calcium	153	42
Trazodone Hcl	Trazodone Hcl	130	41
Lisinopril	Lisinopril	125	37
Tamsulosin Hcl	Tamsulosin Hcl	124	37
Pantoprazole Sodium	Pantoprazole Sodium	115	38
Hydrochlorothiazide	Hydrochlorothiazide	104	29
Alprazolam	Alprazolam	103	30
Ozempic	Semaglutide	94	19
Pioglitazone Hcl	Pioglitazone Hcl	87	24
Escitalopram Oxalate	Escitalopram Oxalate	86	29
Fluoxetine Hcl	Fluoxetine Hcl	84	25
Allopurinol	Allopurinol	82	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	82	20
Metoprolol Tartrate	Metoprolol Tartrate	82	22
Tramadol Hcl	Tramadol Hcl	79	19
Potassium Chloride	Potassium Chloride	74	22
Carvedilol	Carvedilol	70	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	67	13
Eliquis	Apixaban	66	15
Famotidine	Famotidine	64	12
Meloxicam	Meloxicam	64	23
Metformin Hcl Er	Metformin Hcl	64	19
Alendronate Sodium	Alendronate Sodium	61	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	60	20
Irbesartan	Irbesartan	55	19
Duloxetine Hcl	Duloxetine Hcl	54	14
Venlafaxine Hcl Er	Venlafaxine Hcl	54	suppressed
Fluticasone Propionate	Fluticasone Propionate	53	22
Valsartan	Valsartan	52	17
Chlorthalidone	Chlorthalidone	50	15
Finasteride	Finasteride	46	13
Triamcinolone Acetonide	Triamcinolone Acetonide	46	23
Lorazepam	Lorazepam	43	11
Clonidine Hcl	Clonidine Hcl	42	16
Clopidogrel	Clopidogrel Bisulfate	40	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	13
Montelukast Sodium	Montelukast Sodium	40	suppressed
Sertraline Hcl	Sertraline Hcl	38	13
Bupropion Xl	Bupropion Hcl	37	12
Furosemide	Furosemide	37	17
Jardiance	Empagliflozin	37	12
Mirtazapine	Mirtazapine	36	11
Albuterol Sulfate Hfa	Albuterol Sulfate	34	12
Torsemide	Torsemide	34	11
Clonazepam	Clonazepam	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	11
Telmisartan	Telmisartan	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Celecoxib	Celecoxib	26	13
Glimepiride	Glimepiride	26	suppressed
Atenolol	Atenolol	25	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Indapamide	Indapamide	23	suppressed
Rybelsus	Semaglutide	23	suppressed
Glipizide	Glipizide	21	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Olanzapine	Olanzapine	20	suppressed
Amoxicillin	Amoxicillin	18	13
Carbamazepine	Carbamazepine	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Prednisone	Prednisone	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Primidone	Primidone	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Temazepam	Temazepam	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Leucovorin Calcium	Leucovorin Calcium	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Estradiol	Estradiol	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error